Malin Corporation plc

IR:MLC Ireland Drug Manufacturers - Specialty & Generic
Market Cap
$33.75 Million
€32.88 Million EUR
Market Cap Rank
#23528 Global
#7 in Ireland
Share Price
€7.60
Change (1 day)
-5.00%
52-Week Range
€7.00 - €10.30
All Time High
€15.37
About

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It also engages in investment activities. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.

Malin Corporation plc - Asset Resilience Ratio

Latest as of December 2023: 5.49%

Malin Corporation plc (MLC) has an Asset Resilience Ratio of 5.49% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€6.40 Million
Cash + Short-term Investments
Total Assets
€116.60 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2023)

This chart shows how Malin Corporation plc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Malin Corporation plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €6.40 Million 5.49%
Total Liquid Assets €6.40 Million 5.49%

Asset Resilience Insights

  • Limited Liquidity: Malin Corporation plc maintains only 5.49% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Malin Corporation plc Industry Peers by Asset Resilience Ratio

Compare Malin Corporation plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Malin Corporation plc (2018–2023)

The table below shows the annual Asset Resilience Ratio data for Malin Corporation plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 5.49% €6.40 Million €116.60 Million +5.06pp
2020-12-31 0.43% €1.60 Million €370.60 Million +0.09pp
2018-12-31 0.34% €900.00K €264.40 Million --
pp = percentage points